• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Establishment Labs Holdings Inc. - Common Shares (NQ:ESTA)

    69.19 +3.64 (+5.55%)
    Streaming Delayed Price Updated: 2:53 PM EDT, May 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Establishment Labs Holdings Inc. - Common Shares

    < Previous 1 2 3 4 5 Next >
    News headline image
    Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer
    From Route 92 Medical, Inc.
    Via GlobeNewswire
    News headline image
    Establishment Labs Reports First Quarter 2026 Financial Results
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs® Refinances Credit Facility
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Announces Leadership Transition to Support Next Phase of Growth
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Present at TD Cowen's 46th Annual Health Care Conference
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Present at Jefferies London Healthcare Conference
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Reports Third Quarter 2025 Financial Results
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Reports Second Quarter 2025 Financial Results
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Hosting Investor Day on June 12
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Present at Jefferies Global Healthcare Conference
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Reports First Quarter 2025 Financial Results
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Appoints Peter Caldini as Chief Executive Officer
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Announce First Quarter 2025 Financial Results on May 7
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Present at TD Cowen's 45th Annual Health Care Conference
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs to Present at Citi’s 2025 Unplugged Medtech and Life Sciences Access Day
    From Establishment Labs Holdings Inc.
    Via Business Wire
    News headline image
    Establishment Labs Launches Preservé™
    From Establishment Labs Holdings Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.